Profil
Paolo Galfetti is Chief Executive Officer & Director at APR Applied Pharma Research SA since 1995.
Mr. Galfetti is Chief Business Officer at Mindmaze Therapeutics Holding SA. Former roles include Chief Executive Officer & Director at Farma Resa Imp SRL, Chief Executive Officer & Director at Institute For Pharmacokinetic & Analytical Studies, and Chief Operating Officer at RELIEF THERAPEUTICS Holding SA from 2023 to 2024.
Education includes an undergraduate degree from the University of Bocconi.
Aktiva positioner av Paolo Galfetti
| Företag | Position | Start |
|---|---|---|
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Verkställande Direktör | 1995-01-01 |
Tidigare kända positioner av Paolo Galfetti
| Företag | Position | Slut |
|---|---|---|
Institute For Pharmacokinetic & Analytical Studies | Verkställande Direktör | - |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Verkställande Direktör | - |
| MINDMAZE THERAPEUTICS HOLDING SA | Verksamhetschef | 2024-05-08 |
Paolo Galfettis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Bocconi
University of Bocconi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Farma Resa Imp SRL
Farma Resa Imp SRL Pharmaceuticals: MajorHealth Technology Specializes in preparation of pharmaceutical tests | Health Technology |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology Develops and licenses healthcare products and technologies | Health Technology |
RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of biopharmaceutical products for respiratory diseases | Health Technology |
Institute For Pharmacokinetic & Analytical Studies |
















